Company Celyad Oncology SA OTC Markets
Equities
CYADY
US1512052002
Biotechnology & Medical Research
Business Summary
Number of employees: 18
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cardiology
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe and United States
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michel Lussier
FOU | Founder | 67 | 23/07/07 |
David Georges
DFI | Director of Finance/CFO | - | 31/12/18 |
Eytan Breman
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/14 |
An Phan
LAW | General Counsel | 49 | 31/08/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michel Lussier
FOU | Founder | 67 | 23/07/07 |
Hilde Windels
CHM | Chairman | 59 | 06/05/18 |
Serge Goblet
BRD | Director/Board Member | - | 31/12/07 |
Director/Board Member | 53 | 19/01/22 | |
Director/Board Member | - | - | |
Director/Board Member | 50 | 05/05/20 | |
Sage Mandel
BRD | Director/Board Member | - | - |
Marina Udier
BRD | Director/Board Member | - | 10/01/11 |
Ami Patel Shah
BRD | Director/Board Member | - | 07/12/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,428,572 | 38,267,083 ( 92.37 %) | 0 | 92.37 % |
Company contact information
Celyad Oncology SA
Axis Business Park Rue André Dumont 9
1435, Mont-Saint-Guibert
+32 1 039 41 00
http://www.celyad.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |